Results 111 to 120 of about 20,247 (196)

Emerging Immune‐Based Therapeutic Strategies in Hepatocellular Carcinoma

open access: yesLiver International, Volume 46, Issue 8, August 2026.
ABSTRACT Hepatocellular carcinoma (HCC) remains a leading cause of cancer‐related mortality worldwide despite recent advances in systemic therapy. The introduction of immune checkpoint inhibitors has substantially expanded treatment options for advanced disease; however, durable responses are observed only in a subset of patients.
Janine Kah   +2 more
wiley   +1 more source

Additional file 1 of CD47 antibody-armed oncolytic adenovirus promotes chimeric antigen receptor macrophage phagocytosis and antitumor immunity

open access: yes
Supplementary Material ...
Qi, Zhongbing   +10 more
openaire   +1 more source

Impaired CD47–SIRPα Interactions in Antigen‐Priming Results in Defects in Proliferation In Vivo

open access: yesThe FASEB Journal, 2019
Anu Autio   +6 more
openaire   +1 more source

Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interference. [PDF]

open access: yesBlood Neoplasia
Lustig M   +29 more
europepmc   +1 more source

Irinotecan Modulates Immune Checkpoints in Neuroblastoma. [PDF]

open access: yesImmunotargets Ther
Lapidus T   +4 more
europepmc   +1 more source

The LAV-BPIFB4-Platelet-CD47 Axis: A Novel Mechanism Associated With Immune Resilience in Longevity. [PDF]

open access: yesAging Cell
Ciaglia E   +13 more
europepmc   +1 more source

Analysis of Prognostic Significance of CD47 Expression in Newly Diagnosed Large B Cell Lymphoma. [PDF]

open access: yesLife (Basel)
Markovic O   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy